Dendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity

Dendritic cell (DC)-based vaccines are considered useful in cancer immunotherapy, and the interaction of DC and adjuvants is important in the design of the next generation vaccines. In this study, whether DC combined with Rv2299c derived from mycobacteria could improve anti-tumor immune responses in...

Descripción completa

Detalles Bibliográficos
Autores principales: Vo, Manh-Cuong, Lee, Hyun-Ju, Kim, Jong-Seok, Hoang, My-Dung, Choi, Nu-Ri, Rhee, Joon Haeng, Lakshmanan, Vinoth-Kumar, Shin, Sung-Jae, Lee, Je-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741802/
https://www.ncbi.nlm.nih.gov/pubmed/26418952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741802/
https://www.ncbi.nlm.nih.gov/pubmed/26418952

Ejemplares similares